The Ross procedure of aortic valve replacement with a pulmonary autograft h
as several advantages in childhood over mechanical prostheses or homografts
, especially in infectious endocarditis requiring early surgery.
Between January 1997 and July 1998, 3 children with no known previous cardi
ac disease, aged 14 months, 10 and 11 years, had aortic valve infectious en
docarditis. The causal organism was not identified in 1 case and the other
two were due to staphylococcus aureus and corynebacterium diphteriae. All c
hildren had severe, rapidly progressive aortic regurgitation complicated by
pulmonary oedema in the baby and systemic emboli in the two older children
. Surgery was performed within 9 days, 1.5 month and 2 months after the ons
et of the disease. The postoperative course was uncomplicated in the 3 case
s. Postoperative Doppler echocardiography showed absence of autograft dysfu
nction or stenosis, with the presence of pulmonary regurgitation in 1 case.
Pulmonary autograft has the advantages of not requiring anticoagulation, of
allowing growth of the aortic ring, of not being limited by the age of the
patient and of having a low risk of degeneration and infectious endocardit
is. Therefore, it seems particularly indicated for cases of complicated inf
ectious endocarditis requiring early aortic valve replacement. The early (4
.8%) and late (4.3%) mortality rates were comparable to those of other tech
niques and are lower than those associated with valve replacement with mech
anical prostheses in cases of endocarditis (8.5% versus 40%). The secondary
morbidity is 18.8% with dysfunction of the autograft and/or stenosis of th
e pulmonary homograft.
Despite is limited follow-up, aortic valve replacement by a pulmonary homog
raft seems better than aortic valve replacement with a homograft or mechani
cal prosthesis,especially in cases of complicated infectious endocarditis r
equiring surgery in the acute phase. Further studies are required to confir
m these encouraging results.